COVID-19-Associated Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Case Series in a Portuguese Hospital

被引:6
|
作者
Ranhel, David [1 ]
Ribeiro, Ana [1 ]
Batista, Judite [1 ]
Pessanha, Maria [1 ]
Cristovam, Elisabete [1 ]
Duarte, Ana [1 ]
Dias, Ana [1 ]
Coelho, Luis [1 ]
Monteiro, Filipa [1 ]
Freire, Pedro [1 ]
Verissimo, Cristina [2 ]
Sabino, Raquel [2 ,3 ]
Toscano, Cristina [1 ]
机构
[1] Ctr Hosp Lisboa Ocidental, P-1349019 Lisbon, Portugal
[2] Natl Hlth Inst Dr Ricardo Jorge, Infect Dis Dept, P-1649016 Lisbon, Portugal
[3] Univ Lisbon, Fac Med, Inst Saude Ambiental, P-1649028 Lisbon, Portugal
关键词
COVID-19; intensive care unit; Aspergillus; invasive pulmonary aspergillosis; COVID-19-associated invasive pulmonary aspergillosis; COVID-19;
D O I
10.3390/jof7100881
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Invasive pulmonary aspergillosis (IPA) has become a recognizable complication in coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs). Alveolar damage in the context of acute respiratory distress syndrome (ARDS) appears to be the culprit in facilitating fungal invasion in COVID-19 patients, leading to a COVID-19-associated pulmonary aspergillosis (CAPA) phenomenon. From November 2020 to 15 February 2021, 248 COVID-19 patients were admitted to our ICUs, of whom ten patients (4% incidence) were classified as either probable (six) or possible (four) CAPA cases. Seven patients had positive cultural results: Aspergillus fumigatus sensu stricto (five), A. terreus sensu stricto (one), and A. welwitschiae (one). Five patients had positive bronchoalveolar lavage (BAL) and galactomannan (GM), and two patients had both positive cultural and GM criteria. All but two patients received voriconazole. Mortality rate was 30%. Strict interpretation of classic IPA definition would have resulted in eight overlooked CAPA cases. Broader diagnostic criteria are essential in this context, even though differentiation between Aspergillus colonization and invasive disease might be more challenging. Herein, we aim to raise awareness of CAPA in view of its potential detrimental outcome, emphasizing the relevance of a low threshold for screening and early antifungal treatment in ARDS patients.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study
    Gregoire, Emilien
    Pirotte, Benoit Francois
    Moerman, Filip
    Altdorfer, Antoine
    Gaspard, Laura
    Firre, Eric
    Moonen, Martial
    Fraipont, Vincent
    Ernst, Marie
    Darcis, Gilles
    PATHOGENS, 2021, 10 (11):
  • [22] A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold
    Lupia, Tommaso
    Montrucchio, Giorgia
    Gaviraghi, Alberto
    Musso, Gaia
    Puppo, Mattia
    Bolla, Cesare
    Shbaklo, Nour
    Rizzello, Barbara
    Selva, Andrea Della
    Concialdi, Erika
    Rumbolo, Francesca
    Barbui, Anna Maria
    Brazzi, Luca
    De Rosa, Francesco Giuseppe
    Corcione, Silvia
    JOURNAL OF FUNGI, 2022, 8 (12)
  • [23] Surveillance for COVID-19-associated pulmonary aspergillosis
    Brown, Li-An K.
    Ellis, Jayne
    Gorton, Rebecca
    De, Surjo
    Stone, Neil
    LANCET MICROBE, 2020, 1 (04): : E152 - E152
  • [24] COVID-19-Associated Pulmonary Aspergillosis in Russia
    Shadrivova, Olga
    Gusev, Denis
    Vashukova, Maria
    Lobzin, Dmitriy
    Gusarov, Vitaliy
    Zamyatin, Mikhail
    Zavrazhnov, Anatoliy
    Mitichkin, Mikhail
    Borzova, Yulia
    Kozlova, Olga
    Desyatik, Ekaterina
    Burygina, Ekaterina
    Ignatyeva, Svetlana
    Oganesyan, Ellina
    Vasilyeva, Natalya
    Klimko, Nikolay
    Working Grp
    JOURNAL OF FUNGI, 2021, 7 (12)
  • [25] Diagnosing COVID-19-associated pulmonary aspergillosis
    Verweij, Paul E.
    Gangneux, Jean-Pierre
    Bassetti, Matteo
    Bruggemann, Roger J. M.
    Cornely, Oliver A.
    Koehler, Philipp
    Lass-Florl, Cornelia
    van de Veerdonk, Frank L.
    Chakrabarti, Arunaloke
    Hoenigl, Martin
    LANCET MICROBE, 2020, 1 (02): : E53 - E55
  • [26] COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series
    Meijer, Eelco F. J.
    Dofferhoff, Anton S. M.
    Hoiting, Oscar
    Meis, Jacques F.
    MYCOSES, 2021, 64 (04) : 457 - 464
  • [27] A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis
    Vanderbeke, Lore
    Jacobs, Cato
    Feys, Simon
    Resendiz-Sharpe, Agustin
    Debaveye, Yves
    Hermans, Greet
    Humblet-Baron, Stephanie
    Lagrou, Katrien
    Meersseman, Philippe
    Peetermans, Marijke
    Seldeslachts, Laura
    Vanstapel, Arno
    Vande Velde, Greetje
    Van Wijngaerden, Eric
    Wilmer, Alexander
    Verbeken, Erik
    De Hertogh, Gert
    Wauters, Joost
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (03) : 301 - 311
  • [28] COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series
    Singh, Shivam
    Basera, Pragati
    Anand, Aditya
    Ozair, Ahmad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [29] COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?
    Rouze, Anahita
    Lemaitre, Elise
    Nseir, Saad
    INTENSIVE CARE MEDICINE, 2021, 47 (11) : 1337 - 1338
  • [30] COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?
    Anahita Rouzé
    Elise Lemaitre
    Saad Nseir
    Intensive Care Medicine, 2021, 47 : 1337 - 1338